
Search SNP
Search Gene
Search CNV
Search Haplotype
Search Other Variant
Search Region
Search Pathway
Search Study
BD & SZ & MDD shared genes
Total unqiue gene count: 183
Note: The shared genes from cross-disorder studies that investigated the three diseases (BD, SZ and MDD) in one study simultaneously were considered from cross-disorder studies, other overlapped genes between BD-SZ shared genes and BD-MDD shared genes (including both from cross-disorder study and intersection analysis) were all considered from candidate gene intersection analysis.
Approved Symbol | Approved Name | Location | No. of Studies for BD (Positive/Negative/Trend) | Overlap with SZ | Overlap with MDD | ![]() |
---|---|---|---|---|---|---|
SLC6A4 | solute carrier family 6 (neurotransmitter transporter), member 4 | 17q11.2 | 44(18/26/0) | YES | YES | |
BDNF | brain-derived neurotrophic factor | 11p14.1 | 37(24/12/1) | YES | YES | |
COMT | catechol-O-methyltransferase | 22q11.21 | 28(14/14/0) | YES | YES | |
DRD2 | dopamine receptor D2 | 11q22-q23 | 28(8/20/0) | YES | YES | |
HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled | 13q14-q21 | 22(7/15/0) | YES | YES | |
DAOA | D-amino acid oxidase activator | 13q33.2 | 21(13/7/1) | YES | YES | |
MAOA | monoamine oxidase A | Xp11.4-p11.3 | 21(10/11/0) | YES | YES | |
CACNA1C | calcium channel, voltage-dependent, L type, alpha 1C subunit | 12p13.3 | 20(17/3/0) | YES | YES | |
ANK3 | ankyrin 3, node of Ranvier (ankyrin G) | 10q21 | 17(13/3/1) | YES | YES | |
MTHFR | methylenetetrahydrofolate reductase (NAD(P)H) | 1p36.3 | 16(10/6/0) | YES | YES | |
TPH1 | tryptophan hydroxylase 1 | 11p15.3-p14 | 14(5/9/0) | YES | YES | |
DRD4 | dopamine receptor D4 | 11p15.5 | 13(1/12/0) | YES | YES | |
CLOCK | clock circadian regulator | 4q12 | 12(5/7/0) | YES | YES | |
PER2 | period circadian clock 2 | 2q37.3 | 7(1/6/0) | YES | YES | |
PER3 | period circadian clock 3 | 1p36.23 | 7(3/4/0) | YES | YES | |
ARNTL | aryl hydrocarbon receptor nuclear translocator-like | 11p15 | 7(5/2/0) | YES | YES | |
SYNE1 | spectrin repeat containing, nuclear envelope 1 | 6q25.2 | 6(3/2/1) | YES | YES | |
NR1D1 | nuclear receptor subfamily 1, group D, member 1 | 17q11.2 | 6(2/4/0) | YES | YES | |
TENM4 | teneurin transmembrane protein 4 | 11q13 | 6(4/2/0) | YES | YES | |
DGKH | diacylglycerol kinase, eta | 13q13.3 | 6(3/3/0) | YES | YES | |
NPAS2 | neuronal PAS domain protein 2 | 2q11.2 | 5(3/2/0) | YES | YES | |
CSNK1E | casein kinase 1, epsilon | 22q13.1 | 5(1/3/1) | YES | YES | |
CNR1 | cannabinoid receptor 1 (brain) | 6q14-q15 | 5(0/5/0) | YES | YES | |
ACE | angiotensin I converting enzyme | 17q23.3 | 5(2/3/0) | YES | YES | |
CRY2 | cryptochrome circadian clock 2 | 11p11.2 | 5(3/2/0) | YES | YES | |
PER1 | period circadian clock 1 | 17p13.1 | 5(2/3/0) | YES | YES | |
CSNK1D | casein kinase 1, delta | 17q25 | 4(2/2/0) | YES | YES | |
RORB | RAR-related orphan receptor B | 9q22 | 4(3/1/0) | YES | YES | |
BHLHE41 | basic helix-loop-helix family, member e41 | 12p12.1 | 3(2/1/0) | YES | YES | |
CACNB2 | calcium channel, voltage-dependent, beta 2 subunit | 10p12 | 3(2/1/0) | YES | YES | |
TIMELESS | timeless circadian clock | 12q13.3 | 3(0/3/0) | YES | YES | |
GPR50 | G protein-coupled receptor 50 | Xq28 | 3(2/1/0) | YES | YES | |
EGR3 | early growth response 3 | 8p23-p21 | 3(2/1/0) | YES | YES | |
ARNTL2 | aryl hydrocarbon receptor nuclear translocator-like 2 | 12p12.2-p11.2 | 3(1/2/0) | YES | YES | |
ITIH3 | inter-alpha-trypsin inhibitor heavy chain 3 | 3p21.1 | 3(3/0/0) | YES | YES | |
SP8 | Sp8 transcription factor | 7p21.2 | 3(2/0/1) | YES | YES | |
TIPIN | TIMELESS interacting protein | 15q22.31 | 2(0/2/0) | YES | YES | |
CSNK2A1 | casein kinase 2, alpha 1 polypeptide | 20p13 | 2(0/2/0) | YES | YES | |
AANAT | aralkylamine N-acetyltransferase | 17q25.1 | 2(0/2/0) | YES | YES | |
FOXP2 | forkhead box P2 | 7q31 | 2(0/2/0) | YES | YES | |
ABCA13 | ATP-binding cassette, sub-family A (ABC1), member 13 | 7p12.3 | 2(2/0/0) | YES | YES | |
HTR4 | 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled | 5q31-q33 | 2(1/1/0) | YES | YES | |
GNB3 | guanine nucleotide binding protein (G protein), beta polypeptide 3 | 12p13 | 2(1/1/0) | YES | YES | |
ERBB4 | erb-b2 receptor tyrosine kinase 4 | 2q33.3-q34 | 2(1/1/0) | YES | YES | |
MYO18B | myosin XVIIIB | 22q12.1 | 2(0/2/0) | YES | YES | |
NPAS3 | neuronal PAS domain protein 3 | 14q13.1 | 2(1/1/0) | YES | YES | |
CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 2q33 | 2(1/1/0) | YES | YES | |
CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 22q12.3 | 2(1/1/0) | YES | YES | |
NFIL3 | nuclear factor, interleukin 3 regulated | 9q22 | 2(0/2/0) | YES | YES | |
FGFR2 | fibroblast growth factor receptor 2 | 10q25.3-q26 | 2(1/1/0) | YES | YES | |
DRD5 | dopamine receptor D5 | 4p16.1 | 2(0/2/0) | YES | YES | |
NT5C2 | 5'-nucleotidase, cytosolic II | 10q24.32 | 2(2/0/0) | YES | YES | |
YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon | 17p13.3 | 1(0/1/0) | YES | YES | |
CRIM1 | cysteine rich transmembrane BMP regulator 1 (chordin-like) | 2p21 | 1(0/1/0) | YES | YES | |
IFT88 | intraflagellar transport 88 | 13q12.1 | 1(0/1/0) | YES | YES | |
BCL9 | B-cell CLL/lymphoma 9 | 1q21 | 1(1/0/0) | YES | YES | |
TXNL1 | thioredoxin-like 1 | 18q21.31 | 1(0/0/1) | YES | YES | |
NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 2q22-q23 | 1(0/1/0) | YES | YES | |
CCDC102B | coiled-coil domain containing 102B | 18q22.1 | 1(0/1/0) | YES | YES | |
FAM20B | family with sequence similarity 20, member B | 1q25.2 | 1(0/1/0) | YES | YES | |
MDGA1 | MAM domain containing glycosylphosphatidylinositol anchor 1 | 6p21 | 1(1/0/0) | YES | YES | |
AS3MT | arsenite methyltransferase | 10q24.33 | 1(1/0/0) | YES | YES | |
GNB1L | guanine nucleotide binding protein (G protein), beta polypeptide 1-like | 22q11.2 | 1(1/0/0) | YES | YES | |
ACTR3B | ARP3 actin-related protein 3 homolog B (yeast) | 7q36.1 | 1(0/0/1) | YES | YES | |
CTNND2 | catenin (cadherin-associated protein), delta 2 | 5p15.2 | 1(0/1/0) | YES | YES | |
ANXA1 | annexin A1 | 9q21.13 | 1(0/0/1) | YES | YES | |
SAMSN1 | SAM domain, SH3 domain and nuclear localization signals 1 | 21q11 | 1(0/1/0) | YES | YES | |
CCDC68 | coiled-coil domain containing 68 | 18q21 | 1(1/0/0) | YES | YES | |
SEL1L2 | sel-1 suppressor of lin-12-like 2 (C. elegans) | 20p12.1 | 1(0/1/0) | YES | YES | |
ADM | adrenomedullin | 11p15.4 | 1(1/0/0) | YES | YES | |
EIF2AK4 | eukaryotic translation initiation factor 2 alpha kinase 4 | 15q13.3 | 1(0/1/0) | YES | YES | |
FZD3 | frizzled class receptor 3 | 8p21 | 1(0/1/0) | YES | YES | |
CHCHD3 | coiled-coil-helix-coiled-coil-helix domain containing 3 | 7q33 | 1(0/1/0) | YES | YES | |
ANO2 | anoctamin 2, calcium activated chloride channel | 12p13.3 | 1(0/1/0) | YES | YES | |
RBMS3 | RNA binding motif, single stranded interacting protein 3 | 3p24-p23 | 1(0/1/0) | YES | YES | |
PPP2R2D | protein phosphatase 2, regulatory subunit B, delta | 10q26.3 | 1(0/0/1) | YES | YES | |
DHX15 | DEAH (Asp-Glu-Ala-His) box helicase 15 | 4p15.3 | 1(1/0/0) | YES | YES | |
OPTN | optineurin | 10p14 | 1(0/0/1) | YES | YES |
Approved Symbol | Approved Name | Location | No. of Studies for BD (Positive/Negative/Trend) | Overlap with SZ | Overlap with MDD | ![]() |
---|---|---|---|---|---|---|
DRD3 | dopamine receptor D3 | 3q13.3 | 19(4/15/0) | YES | YES | |
DISC1 | disrupted in schizophrenia 1 | 1q42.1 | 18(10/7/1) | YES | YES | |
TH | tyrosine hydroxylase | 11p15.5 | 16(4/12/0) | YES | YES | |
NRG1 | neuregulin 1 | 8p12 | 15(10/5/0) | YES | YES | |
TPH2 | tryptophan hydroxylase 2 | 12q15 | 13(10/3/0) | YES | YES | |
SLC6A3 | solute carrier family 6 (neurotransmitter transporter), member 3 | 5p15.3 | 11(5/6/0) | YES | YES | |
DRD1 | dopamine receptor D1 | 5q34-q35 | 11(6/5/0) | YES | YES | |
P2RX7 | purinergic receptor P2X, ligand gated ion channel, 7 | 12q24 | 9(2/7/0) | YES | YES | |
GSK3B | glycogen synthase kinase 3 beta | 3q13.3 | 8(0/8/0) | YES | YES | |
DTNBP1 | dystrobrevin binding protein 1 | 6p22.3 | 8(4/3/1) | YES | YES | |
NOS1 | nitric oxide synthase 1 (neuronal) | 12q24.22 | 8(2/5/1) | YES | YES | |
GRIN2B | glutamate receptor, ionotropic, N-methyl D-aspartate 2B | 12p13.1 | 8(4/4/0) | YES | YES | |
WFS1 | Wolfram syndrome 1 (wolframin) | 4p16.1 | 7(1/6/0) | YES | YES | |
GRM3 | glutamate receptor, metabotropic 3 | 7q21.1-q21.2 | 7(3/4/0) | YES | YES | |
KCNN3 | potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3 | 1q21.3 | 7(1/6/0) | YES | YES | |
HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled | Xq23 | 7(4/3/0) | YES | YES | |
GABRA5 | gamma-aminobutyric acid (GABA) A receptor, alpha 5 | 15q12 | 6(6/0/0) | YES | YES | |
RGS4 | regulator of G-protein signaling 4 | 1q23.3 | 6(3/2/1) | YES | YES | |
MLC1 | megalencephalic leukoencephalopathy with subcortical cysts 1 | 22q13.33 | 5(1/4/0) | YES | YES | |
TAAR6 | trace amine associated receptor 6 | 6q23.1 | 5(4/1/0) | YES | YES | |
PDLIM5 | PDZ and LIM domain 5 | 4q22 | 5(4/1/0) | YES | YES | |
PBRM1 | polybromo 1 | 3p21 | 5(4/0/1) | YES | YES | |
NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 5q31-q32 | 5(2/3/0) | YES | YES | |
DDC | dopa decarboxylase (aromatic L-amino acid decarboxylase) | 7p12.1 | 5(2/3/0) | YES | YES | |
FKBP5 | FK506 binding protein 5 | 6p21.31 | 5(1/4/0) | YES | YES | |
DUSP6 | dual specificity phosphatase 6 | 12q22-q23 | 5(3/2/0) | YES | YES | |
TSNAX | translin-associated factor X | 1q42.2 | 4(3/1/0) | YES | YES | |
TNF | tumor necrosis factor | 6p21.3 | 4(2/2/0) | YES | YES | |
CHRNA7 | cholinergic receptor, nicotinic, alpha 7 (neuronal) | 15q13.3 | 4(2/2/0) | YES | YES | |
MAOB | monoamine oxidase B | Xp11.4-p11.3 | 4(2/2/0) | YES | YES | |
TSPO | translocator protein (18kDa) | 22q13.3 | 3(1/2/0) | YES | YES | |
PDE4B | phosphodiesterase 4B, cAMP-specific | 1p31 | 3(1/2/0) | YES | YES | |
HTR6 | 5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled | 1p36-p35 | 3(1/2/0) | YES | YES | |
DBP | D site of albumin promoter (albumin D-box) binding protein | 19q13.33 | 3(0/3/0) | YES | YES | |
HTR1A | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled | 5q11.2-q13 | 3(2/1/0) | YES | YES | |
CCL2 | chemokine (C-C motif) ligand 2 | 17q11.2-q21.1 | 3(1/2/0) | YES | YES | |
ADCYAP1 | adenylate cyclase activating polypeptide 1 (pituitary) | 18p11 | 3(1/2/0) | YES | YES | |
NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 9q22.1 | 3(1/1/1) | YES | YES | |
XBP1 | X-box binding protein 1 | 22q12.1 | 3(2/1/0) | YES | YES | |
NCAM1 | neural cell adhesion molecule 1 | 11q23.2 | 3(2/1/0) | YES | YES | |
DBH | dopamine beta-hydroxylase (dopamine beta-monooxygenase) | 9q34 | 3(1/2/0) | YES | YES | |
GNL3 | guanine nucleotide binding protein-like 3 (nucleolar) | 3p21.1 | 2(2/0/0) | YES | YES | |
GABRA1 | gamma-aminobutyric acid (GABA) A receptor, alpha 1 | 5q34 | 2(1/1/0) | YES | YES | |
GNAL | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type | 18p11.22-p11.21 | 2(0/2/0) | YES | YES | |
SOD2 | superoxide dismutase 2, mitochondrial | 6q25 | 2(1/1/0) | YES | YES | |
SLCO3A1 | solute carrier organic anion transporter family, member 3A1 | 15q26 | 2(1/1/0) | YES | YES | |
HSPA1A | heat shock 70kDa protein 1A | 6p21.3 | 2(2/0/0) | YES | YES | |
IFNG | interferon, gamma | 12q14 | 2(2/0/0) | YES | YES | |
CCK | cholecystokinin | 3p22.1 | 2(0/1/1) | YES | YES | |
KCTD12 | potassium channel tetramerization domain containing 12 | 13q21 | 2(0/1/1) | YES | YES | |
NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 | 15q24-q25 | 2(2/0/0) | YES | YES | |
GRIA1 | glutamate receptor, ionotropic, AMPA 1 | 5q33 | 2(2/0/0) | YES | YES | |
SLC6A2 | solute carrier family 6 (neurotransmitter transporter), member 2 | 16q12.2 | 2(0/2/0) | YES | YES | |
S100B | S100 calcium binding protein B | 21q22.3 | 2(1/1/0) | YES | YES | |
NOS3 | nitric oxide synthase 3 (endothelial cell) | 7q36 | 2(1/1/0) | YES | YES | |
FAAH | fatty acid amide hydrolase | 1p35-p34 | 2(0/2/0) | YES | YES | |
GAD1 | glutamate decarboxylase 1 (brain, 67kDa) | 2q31 | 2(1/1/0) | YES | YES | |
HTR5A | 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled | 7q36.1 | 2(1/1/0) | YES | YES | |
HTR3B | 5-hydroxytryptamine (serotonin) receptor 3B, ionotropic | 11q23.1 | 2(1/1/0) | YES | YES | |
SNAP25 | synaptosomal-associated protein, 25kDa | 20p12-p11.2 | 2(2/0/0) | YES | YES | |
INPP1 | inositol polyphosphate-1-phosphatase | 2q32 | 1(0/1/0) | YES | YES | |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | 16q12-q22 | 1(0/1/0) | YES | YES | |
RGMA | repulsive guidance molecule family member a | 15q26.1 | 1(1/0/0) | YES | YES | |
GRM2 | glutamate receptor, metabotropic 2 | 3p21.2 | 1(0/1/0) | YES | YES | |
SYN2 | synapsin II | 3p25.2 | 1(0/1/0) | YES | YES | |
GRIK3 | glutamate receptor, ionotropic, kainate 3 | 1p34.3 | 1(1/0/0) | YES | YES | |
NR3C2 | nuclear receptor subfamily 3, group C, member 2 | 4q31 | 1(1/0/0) | YES | YES | |
SLC18A2 | solute carrier family 18 (vesicular monoamine transporter), member 2 | 10q25 | 1(1/0/0) | YES | YES | |
CCKBR | cholecystokinin B receptor | 11p15.4 | 1(1/0/0) | YES | YES | |
PAWR | PRKC, apoptosis, WT1, regulator | 12q21.2 | 1(0/1/0) | YES | YES | |
HTR1D | 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled | 1p36.3-p34.3 | 1(0/1/0) | YES | YES | |
INS | insulin | 11p15.5 | 1(0/1/0) | YES | YES | |
GRIA3 | glutamate receptor, ionotropic, AMPA 3 | Xq25 | 1(0/1/0) | YES | YES | |
GNAS | GNAS complex locus | 20q13.2-q13.3 | 1(0/1/0) | YES | YES | |
KLK8 | kallikrein-related peptidase 8 | 19q13 | 1(1/0/0) | YES | YES | |
EGR1 | early growth response 1 | 5q23-q31 | 1(0/1/0) | YES | YES | |
APOE | apolipoprotein E | 19q13.31 | 1(1/0/0) | YES | YES | |
ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | 7q21.12 | 1(1/0/0) | YES | YES | |
GDNF | glial cell derived neurotrophic factor | 5p13.1-p12 | 1(1/0/0) | YES | YES | |
GAD2 | glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) | 10p13-p11.2 | 1(0/1/0) | YES | YES | |
IL6 | interleukin 6 | 7p21-p15 | 1(0/1/0) | YES | YES | |
VIPR2 | vasoactive intestinal peptide receptor 2 | 7q36.3 | 1(1/0/0) | YES | YES | |
IL10 | interleukin 10 | 1q31-q32 | 1(0/1/0) | YES | YES | |
PIK3C2A | phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha | 11p15.5-p14 | 1(0/1/0) | YES | YES | |
ESR1 | estrogen receptor 1 | 6q24-q27 | 1(0/1/0) | YES | YES | |
SST | somatostatin | 3q28 | 1(0/1/0) | YES | YES | |
USP46 | ubiquitin specific peptidase 46 | 4q12 | 1(0/1/0) | YES | YES | |
MBP | myelin basic protein | 18q23 | 1(1/0/0) | YES | YES | |
PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 5q13.1 | 1(1/0/0) | YES | YES | |
ADRA2A | adrenoceptor alpha 2A | 10q25.2 | 1(0/1/0) | YES | YES | |
PENK | proenkephalin | 8q23-q24 | 1(0/1/0) | YES | YES | |
GFAP | glial fibrillary acidic protein | 17q21 | 1(1/0/0) | YES | YES | |
OXTR | oxytocin receptor | 3p25 | 1(0/1/0) | YES | YES | |
GLT8D1 | glycosyltransferase 8 domain containing 1 | 3p21.1 | 1(1/0/0) | YES | YES | |
QKI | QKI, KH domain containing, RNA binding | 6q26 | 1(0/1/0) | YES | YES | |
SIRT1 | sirtuin 1 | 10q21 | 1(0/1/0) | YES | YES | |
GRIN2A | glutamate receptor, ionotropic, N-methyl D-aspartate 2A | 16p13.2 | 1(1/0/0) | YES | YES | |
IL1B | interleukin 1, beta | 2q14 | 1(1/0/0) | YES | YES | |
PCNT | pericentrin | 21q22.3 | 1(0/1/0) | YES | YES | |
SLC1A2 | solute carrier family 1 (glial high affinity glutamate transporter), member 2 | 11p13-p12 | 1(1/0/0) | YES | YES | |
CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | 6p22.3 | 1(0/1/0) | YES | YES | |
GABRB2 | gamma-aminobutyric acid (GABA) A receptor, beta 2 | 5q34 | 1(1/0/0) | YES | YES | |
SLIT3 | slit homolog 3 (Drosophila) | 5q35 | 1(1/0/0) | YES | YES | |
APOD | apolipoprotein D | 3q29 | 1(0/1/0) | YES | YES | |
MED12 | mediator complex subunit 12 | Xq13 | 1(0/1/0) | YES | YES |